Results 81 to 90 of about 5,255 (177)

Retraction: SiC ultra -thin films for high-performance quantum spacecraft applications fabricated via nanosecond pulsed laser deposition and doping. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Views, Barriers and Facilitators  of Policymakers, Pharmacists and Community Health Representative in Managing Unused Medicine in a Socioeconomically Diverse District in Indonesia. [PDF]

F1000Res
Syamsudin RAMR, Kristina SA, Wiedyaningsih C, Lai PSM.   +3 more
europepmc   +1 more source

Contesting an exclusive citizenship regime: the Kurdistan Workers Party (PKK) and its electoral mobilisation in Batman in the late 1970s. [PDF]

Third World Q
Jongerden J, O'Connor F.
europepmc   +1 more source

Association of muscle instability and long-term prophylaxis in hereditary angioedema. [PDF]

World Allergy Organ J
Hollers E, Yu Y, Sheetz J, Richwine K, Grim K, Germak-Sovereign R, Luong L, Hitomi H, Al-Shaikhly T, Craig T.   +9 more
europepmc   +1 more source

Bioactive Peptides from Skipjack Tuna Cardiac Arterial Bulbs (II): Protective Function on UVB-Irradiated HaCaT Cells through Antioxidant and Anti-Apoptotic Mechanisms. [PDF]

Mar Drugs, 2023
Kong J, Hu XM, Cai WW, Wang YM, Chi CF, Wang B.   +5 more
europepmc   +1 more source

Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study. [PDF]

Allergy Asthma Clin Immunol
Betschel SD, Chapdelaine H, Gagnon R, Goodyear MD, Keith PK, El-Zoeiby A, Khutoryansky N, Castaner DN.   +7 more
europepmc   +1 more source

Interplay between Structure and Conduction Mechanism of Piperazinium-Functionalized Poly[Ethylene Pyrrole/Ethylene Ketone/Propylene Ketone] Anion Conducting Membranes. [PDF]

ChemSusChem
Alvi AR, Vezzù K, Lanero F, Sgarbossa P, Nale A, Di Noto V.   +5 more
europepmc   +1 more source

Two species of <i>Atteva</i> Walker, 1854 (Lepidoptera, Attevidae) new to Laos, with DNA barcodes. [PDF]

Biodivers Data J
Na SM, Shin NR, Bae YS.
europepmc   +1 more source

TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration. [PDF]

Eye (Lond)
Regillo C, Kaiser PK, Kertes PJ, Gillies M, Maio-Twofoot T, Lawrence D, Holz FG.   +6 more
europepmc   +1 more source

Serious adverse events, readmission, and mortality after shoulder replacement due to fracture, osteoarthritis, and other indications: a population-based comparison with the general population. [PDF]

Acta Orthop
Larsen JM, Stisen MG, Kristensen PK, Launonen AP, Thillemann TM, Mechlenburg I.   +5 more
europepmc   +1 more source